CD56 and PGP expression in acute myeloid leukemia: impact on clinical outcome.
about
Expression of CD56 is an unfavorable prognostic factor for acute promyelocytic leukemia with higher initial white blood cell countsClinical impact of CD200 expression in patients with acute myeloid leukemia and correlation with other molecular prognostic factors.Prognostic significance of flow cytometric immunophenotyping in acute myeloid leukemia.Specific detection of CD56 (NCAM) isoforms for the identification of aggressive malignant neoplasms with progressive development.Clinical Courses of Two Pediatric Patients with Acute Megakaryoblastic Leukemia Harboring the CBFA2T3-GLIS2 Fusion Gene
P2860
CD56 and PGP expression in acute myeloid leukemia: impact on clinical outcome.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
CD56 and PGP expression in acute myeloid leukemia: impact on clinical outcome.
@en
CD56 and PGP expression in acute myeloid leukemia: impact on clinical outcome.
@nl
type
label
CD56 and PGP expression in acute myeloid leukemia: impact on clinical outcome.
@en
CD56 and PGP expression in acute myeloid leukemia: impact on clinical outcome.
@nl
prefLabel
CD56 and PGP expression in acute myeloid leukemia: impact on clinical outcome.
@en
CD56 and PGP expression in acute myeloid leukemia: impact on clinical outcome.
@nl
P2093
P1433
P1476
CD56 and PGP expression in acute myeloid leukemia: impact on clinical outcome
@en
P2093
Angela Michelutti
Antonella Geromin
Daniela Damiani
Donatella Raspadori
Francesco Lauria
Mariagrazia Michieli
Paola Masolini
Raffaella Stocchi
Renato Fanin
Sara Gentili
P304
P577
2002-11-01T00:00:00Z